Identification of Serum Markers For Tumor Hypoxia in Non-Small Cell Lung Cancers

NCT00185913CI-TRIAL-00003384completedClinicalTrials.gov clinicaltrialsPublishedExplore in graph →

Summary

Brief summary (as posted)

The purpose of the study is to identify a surrogate serum marker for tumor hypoxia in patients with lung cancers.

Conditions

Conditions (1)

Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.

Condition (as posted)	Mapped entity	Match	Confidence
Lung Cancer	Malignant Lung Neoplasm	CURATED_EXACT	0.92

Interventions

Interventions (0)

Data not yet available

No intervention recorded.

Eligibility

Eligibility (as posted)

Sex: All
Minimum age: 18 Years

Show eligibility criteria text

Inclusion Criteria:- Newly diagnosed patients with lung cancer who are undergoing surgical resection of their tumors Exclusion Criteria:- Patients without non-small cell lung cancer

References

Publications (0)

Data not yet available

No reference posted for this study.

Registry

Dates and enrollment

Start: Sep 1, 2000
Primary completion: Oct 1, 2003
Completion: May 1, 2008
First posted: Sep 16, 2005
Last update posted: Apr 22, 2010
Enrollment: 50 (estimated)
Lead sponsor: Stanford University OTHER

Data updated 22 days agoSource updated Apr 22, 2010source: clinicaltrials

Locations

Locations by country (1)

Country	Sites	Recruiting
United States	1	0

Trial listing is informational. Eligibility is decided by the study team; contact information is on ClinicalTrials.gov.